Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials
about
An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort studyClinical Features and Outcomes of IPF Patients Hospitalized for Pulmonary Infection: A Japanese Cohort Study.TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary FibrosisEffect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis.Novel Drug Targets For Idiopathic Pulmonary Fibrosis.Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.High Attenuation Areas on Chest CT and Clinical Respiratory Outcomes in Community-dwelling Adults.Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.Clarity on Endpoints for Clinical Trials in Idiopathic Pulmonary Fibrosis.Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.African-American Race and Mortality in Interstitial Lung Disease: A Multicenter Propensity-Matched Analysis.Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis.
P2860
Q33714184-014F58B1-573C-46CD-BF28-286AB5E36610Q36181514-9729E5FF-28D3-48B5-BF56-C761C909DBC4Q36222034-051AABA7-A592-4A38-B541-1EC65FBC8D30Q36516894-7EF6AFC0-CE19-4100-AA9D-47B7A2D9EFF6Q37616955-DF7933E8-3967-47A7-AA9D-B27126FA0765Q38725808-5A405228-CBB5-4CB6-8B8E-2871356C02ADQ38804833-3368A727-DF6B-48D9-A1D9-B60082A27B3DQ39950937-B73D93C7-58C9-46AC-AC35-82CA6DA1E65BQ40160454-2727A448-48CE-4F67-BC62-686F5A55EE0CQ40234409-2A1BA1D1-2F3C-4BDE-A39E-50DE958DB2B0Q46863202-20DCBE17-8771-4EAE-883D-176AA5B1F04EQ48304185-F4CE2C6F-631E-41BA-A274-7C7B3FC250CBQ53686363-C231491E-58F0-45A6-9B09-1A4D0ADEA98DQ55414885-5EA6EECE-DEB1-4EF1-9D81-015E51FADFAC
P2860
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Association of hospital admiss ...... ort from three clinical trials
@ast
Association of hospital admiss ...... ort from three clinical trials
@en
type
label
Association of hospital admiss ...... ort from three clinical trials
@ast
Association of hospital admiss ...... ort from three clinical trials
@en
prefLabel
Association of hospital admiss ...... ort from three clinical trials
@ast
Association of hospital admiss ...... ort from three clinical trials
@en
P2093
P2860
P1476
Association of hospital admiss ...... ort from three clinical trials
@en
P2093
Fernando J Martinez
Ganesh Raghu
Harold R Collard
IPFnet investigators
Kevin J Anstrom
Kevin K Brown
Kevin R Flaherty
Rhonda S Roberts
Scott M Palmer
Talmadge E King
P2860
P304
P356
10.1016/S2213-2600(15)00093-4
P577
2015-04-15T00:00:00Z